Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Running The Gauntlet: Takeaways From The First Round Of HHS Hearings In 2019

Mar 21 2019

• By Michael McCaughan

US Capitol building at night

Related Content

Pharma In The Crosshairs: Dual Drug Pricing Hearings Portend Rocky Road Ahead – And Potential Subpoenas

Feb 04 2019

CMS Part D Protected Class Restrictions Drawing Bipartisan Concerns In Congress

Mar 13 2019

Trump FY 2020 Budget Renews Push To Reform 180-Day Exclusivity

Mar 12 2019

New Acting US FDA Commissioner Shares Agency's Clinical Trial Reform Message

Mar 13 2019

Part D Premiums ‘Won’t Go Up’ With HHS Rebate Proposal, Azar Maintains

Mar 14 2019

Democratic Oversight And Trump’s Rx Price Blueprint: Three Possible Routes

Jan 23 2019

Additional Topics

United States Legislation Leadership Pricing Debate Policy BioPharmaceutical

More from Legislation

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window